Treatment of Locally Advanced Melanoma by Isolated Limb Infusion with Cytotoxic Drugs

Abstract EN

Since its introduction in the late 1950s, isolated limb perfusion (ILP) has been the preferred treatment option for locally advanced melanoma and sarcoma confined to a limb.

This treatment results in high response rates with a satisfying duration of response in both tumor types.

A drawback of ILP, however, is the invasive and complex character of the procedure.

Isolated limb infusion (ILI) has been designed in the early 1990s as a minimally invasive alternative to ILP.

Results of this simple procedure, reported by various centers around the world, show comparable response rates for melanoma and sarcoma when compared to ILP.

Due to its minimally invasive character, ILI may replace ILP in the future as the preferred treatment for these locally advanced limb tumors.